Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.


Latest Press Releases

Just - Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access
Healthcare & PharmaceuticalCompany Update

Just - Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access

January 8, 2026 1:50 AM

Evotec SE (NASDAQ:EVO)(Frankfurt Prime Standard:EVT) today announces that its Seattle-based subsidiary, Just - Evotec Biologics, Inc., has received a new grant from the Gates Foundation to enable global access to biotherapeutics utilizing Just - Evotec Biologics' molecular design suite of computational technologies, called "J.MD™". Investment (INV072135) continues the support for selected Gates Foundation grantees to improve the developability...

Read more
Obituary Notice: Peter Schlesinger, 19-Time Emmy Award-Winning Television Producer and Longtime KCOP-TV Program Director
Healthcare & PharmaceuticalCompany Update

Obituary Notice: Peter Schlesinger, 19-Time Emmy Award-Winning Television Producer and Longtime KCOP-TV Program Director

January 7, 2026 9:25 PM

It is with great sadness that we announce the passing of Peter Schlesinger, a noted figure in the television industry who served as Program Director for KCOP-TV from 1971 to 2001 and as a multiple Emmy Award-winning Executive Producer for both national and local television programming. Peter passed away on December 5 in Calabasas. Peter entered the television industry in the late 1950's as a staff director for a local Rockford, Illinois station...

Read more
The Assistance Fund Opens New Program for Myeloproliferative Neoplasms
Healthcare & PharmaceuticalCompany Update

The Assistance Fund Opens New Program for Myeloproliferative Neoplasms

January 7, 2026 4:40 PM

The Assistance Fund, an independent charitable patient assistance organization that helps patients and families facing high medical out-of-pocket costs, today announced the launch of a new copay assistance program for people living with myeloproliferative neoplasms (MPN). The program is designed to help eligible individuals pay for their out-of-pocket medical costs for treatment, such as copays, coinsurance, and deductibles. A rare blood cancer,...

Read more
Citrus Burn Reviews (DOCTOR REVEALS) The Truth Behind the Citrus Fat-Burning Mechanism
Healthcare & PharmaceuticalAdvertorial

Citrus Burn Reviews (DOCTOR REVEALS) The Truth Behind the Citrus Fat-Burning Mechanism

January 7, 2026 4:00 PM

For years, metabolic science has chased the wrong problem. Most weight loss supplements attempt to force fat burning with stimulants, yet millions of adults over 35 continue to report stalled results, stubborn fat, and declining energy despite disciplined diets and exercise. What quietly shocked researchers was not another stimulant, but a citrus-derived metabolic mechanism that appeared to re-sensitize thermogenic pathways instead of...

Read more
FDA-Cleared Microbicidal Polymer Kills Deadly, Drug-Resistant Candida Auris Superbug on Contact
Healthcare & PharmaceuticalProduct Announcements

FDA-Cleared Microbicidal Polymer Kills Deadly, Drug-Resistant Candida Auris Superbug on Contact

January 7, 2026 4:00 PM

Scientists have identified a new ally in the battle against the deadly outbreak of the superbug Candida auris, currently spreading rapidly throughout U.S. Hospitals and becoming even more threatening worldwide. An independent laboratory study shows that Preventogen, an FDA-cleared microbicidal liquid polymer, kills 99.99 percent of the C. auris fungus on contact. The triple-action liquid product, which eliminates drug-resistant bacteria, viruses...

Read more
Emerging Growth Research Maintains Buy-Extended Rating on SBC Medical Group Holdings, Inc. with $9.00 Price Target Following Strategic U.S. Market Entry
Healthcare & PharmaceuticalCompany Update

Emerging Growth Research Maintains Buy-Extended Rating on SBC Medical Group Holdings, Inc. with $9.00 Price Target Following Strategic U.S. Market Entry

January 7, 2026 12:20 PM

Emerging Growth Research today announced the release of its Flash Report on SBC Medical Group Holdings, Inc. (Nasdaq:SBC), maintaining a Buy-Extended rating and its 12-month price target of $9.00, representing significant upside from the Company's closing price of $4.44 on January 6, 2026. The Flash Report highlights SBC's major milestone entry into the United States medical aesthetics market through a strategic minority equity investment and...

Read more
TRNR Provides Shareholder Update on Sportstech Process & Operating Strategy
Healthcare & PharmaceuticalCompany Update

TRNR Provides Shareholder Update on Sportstech Process & Operating Strategy

January 7, 2026 10:30 AM

Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the Wattbike, CLMBR and FORME brands, today announced that it has published a shareholder letter updating investors with respect to the Sportstech loan and acquisition process and providing additional context about its improved operating scale and near-term plans. Shareholders may also visit www.interactivestrength.com and...

Read more
EDGE Surgical Launches Universal Depth Gauge - A Breakthrough in Orthopedics
Healthcare & PharmaceuticalProduct Announcements

EDGE Surgical Launches Universal Depth Gauge - A Breakthrough in Orthopedics

January 7, 2026 10:09 AM

EDGE Surgical, Inc, the innovative brand behind the world's only electronic depth gauge for orthopedic surgery, today announced the launch of a Universal Depth Gauge compatible with all major orthopedic plating systems. With patent-pending dynamic calibration technology, the Ortho EDG® is the world's first depth gauge to work with every major plating system - a quantum leap forward in depth gauge technology. The Universal Depth Gauge furthers...

Read more
AMEEREX Enters Strategic Partnership With Patagonia Lithium (ASX: PL3), Gaining Exposure to Inferred and Indicated 551,000 tonnes of Lithium Carbonate Equivalent JORC-Validated Lithium Resource by WSP Australia
Healthcare & PharmaceuticalMergers and Acquisitions

AMEEREX Enters Strategic Partnership With Patagonia Lithium (ASX: PL3), Gaining Exposure to Inferred and Indicated 551,000 tonnes of Lithium Carbonate Equivalent JORC-Validated Lithium Resource by WSP Australia

January 7, 2026 10:05 AM

AMEEREX Corporation ("Ameerex" or the "Company") today announced that it has entered into a strategic partnership with Patagonia Lithium Limited (ASX:PL3), working towards securing a material economic interest in a world-class lithium brine resource located in Argentina's Lithium Triangle, one of the most important lithium-producing regions globally. The announcement follows Patagonia Lithium's disclosure of a Significant Maiden Inferred...

Read more
Medical Care Technologies' Infinite Auctions to Offer Original Art by Iconic Artist Rob Prior Signed by Stan Lee, Chris Evans, Al Pacino & More
Healthcare & PharmaceuticalCompany Update

Medical Care Technologies' Infinite Auctions to Offer Original Art by Iconic Artist Rob Prior Signed by Stan Lee, Chris Evans, Al Pacino & More

January 7, 2026 9:30 AM

Medical Care Technologies Inc. (OTC Pink:MDCE) is excited to announce that its subsidiary, Infinite Auctions, will host "The Legends Art Auction," an exclusive event showcasing a remarkable collection of original art pieces by renowned artist Rob Prior and others. This highly anticipated auction will feature: Captain America artwork signed by actor Chris Evans Three original paintings of Stan Lee and Marvel characters Original painting of Peyton...

Read more
Phase 1 Equity Announces it's First Practice Addition of The Year, Bringing on a Multi-Site Orthodontic Practice Located in Ohio
Healthcare & PharmaceuticalCompany Update

Phase 1 Equity Announces it's First Practice Addition of The Year, Bringing on a Multi-Site Orthodontic Practice Located in Ohio

January 7, 2026 9:00 AM

Phase 1 Equity, a doctor-owned, doctor-led, and doctor-governed platform for orthodontists and pediatric dentists, is excited to welcome another leading multi-site orthodontic practice based in Ohio to its growing network. This practice treats each patient as a family member and delivers flexibility in offering highly personalized care backed by state-of-the-art technology. This community-based practice thrives on delivering exceptional care...

Read more
Revelation Biosciences Announces Initiation of GMP Manufacturing of GEMINI and Placebo to Support Later Stage Clinical Development
Healthcare & PharmaceuticalCompany Update

Revelation Biosciences Announces Initiation of GMP Manufacturing of GEMINI and Placebo to Support Later Stage Clinical Development

January 7, 2026 9:00 AM

Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on rebalancing inflammation, today announced the start of GMP manufacturing of GEMINI and placebo. This manufacturing run will provide the Company with clinical drug supply for later stage clinical studies. "We are delighted to be working with a leading global contract manufacturing organization," said James Rolke,...

Read more
Aspire Biopharma Announces Successful Pre-IND Meeting with FDA for High-Dose Sublingual Aspirin (OTASA)
Healthcare & PharmaceuticalRegulatory

Aspire Biopharma Announces Successful Pre-IND Meeting with FDA for High-Dose Sublingual Aspirin (OTASA)

January 7, 2026 8:00 AM

Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a biopharmaceutical company developing multi-faceted patent-pending drug delivery technology, today announced the successful outcome of a Type B pre-Investigational New Drug (IND) meeting with the U.S. Food and Drug Administration (FDA). The meeting provided a clear regulatory roadmap for the Company's investigational new drug, acetylsalicylic acid 162 mg sublingual...

Read more
Ovation Science Secures New Canadian Patent; Strengthening IP Position and Expanding Commercial Opportunities for Topical Cannabis Products
Healthcare & PharmaceuticalCompany Update

Ovation Science Secures New Canadian Patent; Strengthening IP Position and Expanding Commercial Opportunities for Topical Cannabis Products

January 7, 2026 8:00 AM

Ovation Science Inc. (CSE:OVAT)(OTC PINK:OVATF) ("Ovation" or the "Company"), a research and development company focused on the commercialization, patenting, and licensing of advanced cannabinoid-based topical / transdermal products, today announced the issuance of a new Canadian patent covering proprietary topical formulations containing CBD and THC. The patent, entitled "Composition and method for transdermal delivery of cannabidiol (CBD) and...

Read more
Wellgistics Health Provides 2026 Corporate Outlook
Healthcare & PharmaceuticalCompany Update

Wellgistics Health Provides 2026 Corporate Outlook

January 7, 2026 7:40 AM

Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a health information technology leader, integrating proprietary pharmacy dispensing optimization artificial intelligence (‘AI') platform EinsteinRx™ into its patented blockchain-enabled smart contracts platform PharmacyChain™, today provided a corporate outlook for 2026 to stakeholders. "Three months following my return to the role of President at Wellgistics, the Company now has a clear...

Read more
Protagonist Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference 2026
Healthcare & PharmaceuticalCompany Update

Protagonist Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference 2026

January 7, 2026 7:30 AM

Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will present a company overview at the 44th Annual J.P. Morgan Healthcare Conference taking place January 12-15, 2026 in San Francisco, CA. The Company will also participate in one-on-one meetings. 44th Annual J.P. Morgan Healthcare Conference - January 12-15, 2026 Format: Company Presentation...

Read more
Neurodivergent Empowerment Institute Presents: New Moon Drum Circle and Sound Bath
Healthcare & PharmaceuticalEnvironmental, Social and Governance

Neurodivergent Empowerment Institute Presents: New Moon Drum Circle and Sound Bath

January 7, 2026 7:00 AM

The Neurodivergent Empowerment Institute, part of the Bionic Bloom Wellness Collective family of wellness centers, invites the community to a transformative New Moon Drum Circle and Sound Bath on Sunday, January 18, 2026 from 6:00 PM to 8:00 PM EST at NEI's St. Petersburg campus. (Humanitix) This guided New Moon experience offers a supportive space for participants to release what no longer serves them, set intentions for the coming lunar cycle,...

Read more
Patient Outcomes First: How James Richman's OTLEN Brings AI to Clinics
Healthcare & PharmaceuticalCompany Update

Patient Outcomes First: How James Richman's OTLEN Brings AI to Clinics

January 7, 2026 6:00 AM

For most patients, the frustrations of the healthcare system are measured in minutes spent in waiting rooms or months waiting for insurance approvals. But for James Richman, a financier turned technology CEO, the problem is measured in something else entirely: the invisible "handoffs" where vital data - and billions of dollars - simply disappear. Richman is the CEO of OTLEN, a company that has quietly positioned itself as the "central nervous...

Read more
AMC Health Announces Breakthrough in AI-Driven Alert Precision for Virtual Care Program
Healthcare & PharmaceuticalCompany Update

AMC Health Announces Breakthrough in AI-Driven Alert Precision for Virtual Care Program

January 7, 2026 6:00 AM

AMC Health, a leading provider of virtual care and chronic condition management, today announced a major advancement in its AI-driven clinical alerting framework. This AI-driven framework uses longitudinal, patient-specific baselines and time-series pattern detection to significantly improve the precision of physiometric alerts while reducing unnecessary clinician workload, without compromising patient safety or outcomes. Leveraging more than...

Read more
Amphastar Pharmaceuticals to Present at the J.P. Morgan 2026 Healthcare Conference
Healthcare & PharmaceuticalConferences

Amphastar Pharmaceuticals to Present at the J.P. Morgan 2026 Healthcare Conference

January 7, 2026 6:00 AM

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jack Zhang, CEO and President, and Bill Peters, CFO will be presenting at the J.P. Morgan 2026 Healthcare Conference on Wednesday, January 14th, 2026, at 2:15 pm PT. For access, visit Amphastar's Pharmaceuticals website at http://ir.amphastar.com. This webcast will be available for 30 days following the presentation. About Amphastar Pharmaceuticals, Inc.: Amphastar is a...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers • July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie • July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers • July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers • June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers • June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers • June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?